Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.

AusPAR: Sorafenib

Australian Public Assessment Report

AusPAR

AusPAR: Sorafenib [PDF, 577.02 KB]

AusPAR: Sorafenib [Word, 983.78 KB]

Attachment: Product Information: Sorafenib [PDF, 578.37 KB]

Attachment: Product Information: Sorafenib [Word, 451.79 KB]

Attachment: Extract from Clinical Evaluation Report: Sorafenib [PDF, 2.28 MB]

Attachment: Extract from Clinical Evaluation Report: Sorafenib [Word, 4.43 MB]

Device/Product Name

Nexavar

Active ingredients

Sorafenib

AusPAR Date

6 August 2014

Published

25 August 2014

Submission Number

PM-2013-02057-1-4

Submission Type

Extension of indications, Changes to Product Information

Decision

Approved